Clinical Trial Update: A Single-dose Phase 1 Study of DBPR108 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A single-dose Phase 1 study of DBPR108 was conducted in healthy male subjects, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DBPR108 (DBPR108)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2014-08-28